Increased soluble Fas plasma levels in subjects at high cardiovascular risk - Atorvastatin on inflammatory markers (AIM) study, a substudy of ACTFAST

Blanco-Colio, L.M. et al. (2007) Increased soluble Fas plasma levels in subjects at high cardiovascular risk - Atorvastatin on inflammatory markers (AIM) study, a substudy of ACTFAST. Arteriosclerosis, Thrombosis, and Vascular Biology, 27, pp. 168-174. (doi: 10.1161/01.ATV.0000250616.26308.d7)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Gaw, Dr Allan
Authors: Blanco-Colio, L.M., Martin-Ventura, J.L., de Teresa, E., Farsang, C., Gaw, A., Gensini, G., Leiter, L.A., Langer, A., Martineau, P., Hernandez, G., Egido, J., and ACTFAST Investigators,
College/School:College of Medical Veterinary and Life Sciences
College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name:Arteriosclerosis, Thrombosis, and Vascular Biology
Publisher:American Heart Association
ISSN:1079-5642

University Staff: Request a correction | Enlighten Editors: Update this record